Worse Cancer Mortality Seen in Association With Exposure to Coal Operations
via HealthDayTUESDAY, May 26, 2026 -- Occupational exposure and residential exposure to coal operations are associated with worse cancer mortality, according to a review published online May 19 in Public Health.
Leticia M. Nogueira, Ph.D., M.P.H., from the American Cancer Society in Atlanta, and colleagues conducted a systematic review on cancer risk and outcomes associated with exposure to coal operations in the United States. Forty-five unique articles were included.
The researchers found statistically significant outcomes in all 18 studies that evaluated residential exposures and cancer mortality. Similarly, statistically significant associations with increased cancer mortality were seen in all occupational studies published after 2003. The most common limitations of studies included in the review were competing risks, healthy worker bias, and ecological fallacy. Mixed findings were seen in 19 studies evaluating residential or occupational exposure to coal operations and cancer incidence; in the single study of cancer-related hospitalizations, no significant association was found with residential exposure.
"Our findings add further evidence that coal exposure increases your cancer risk, both for people who work with coal and for people who live near coal infrastructure. It's why environmental protections can't be rolled back, as it could accelerate dangers from carcinogens and other pollutants in surrounding communities," Nogueira said in a statement. "Exposing more people to pollutants can also cause an economic burden on communities, resulting from premature mortality, increased health care costs, and a decline of natural resources that support local livelihoods and well-being.”
One author disclosed receiving royalties from coal activities conducted on inherited and multi-heir-owned properties.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-27 09:58
Read more
- Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease
- FDA Approves Inqovi for Acute Myeloid Leukemia
- Study Looks at Outcomes of Endoscopic Surgery in Men With BPH, Overactive Bladder
- Major Review: Antidepressants Safe in Pregnancy, No Added Risk of Autism or ADHD in Kids
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- VR Training Helps Autistic People Navigate Police Encounters
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions